Revenue | ₹8,833.91Cr |
Net Profits | ₹910.29Cr |
Net Profit Margins | 10.30% |
Aurobindo Pharma Ltd’s revenue jumped 8.56% since last year same period to ₹8,833.91Cr in the Q3 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 5.07% jump in its revenue since last 3-months.
Aurobindo Pharma Ltd’s net profit jumped 7.62% since last year same period to ₹910.29Cr in the Q3 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 7.29% jump in its net profits since last 3-months.
Aurobindo Pharma Ltd’s net profit margin fell -0.86% since last year same period to 10.30% in the Q3 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 2.12% jumped in its net profit margins since last 3-months.
The revenue for Aurobindo Pharma Ltd in the Q3 results 2025 was ₹8,833.91Cr.
The net profit for Aurobindo Pharma Ltd in the Q3 results 2025 was ₹910.29Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q3 results 2025 was 10.30%.
The revenue for Aurobindo Pharma Ltd in the Q3 results 2024 was ₹8,137.40Cr.
The net profit for Aurobindo Pharma Ltd in the Q3 results 2024 was ₹845.81Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q3 results 2024 was 10.39%.